Non-Invasive Prenatal Testing NIPT | Genetic Testing

What is NIPT?

MedGenome Claria NIPT is a simple, safe, and non-invasive prenatal screening test that provides assurance to expectant parents with accurate genetic information about their baby. The test uses advanced bioinformatics technology to evaluate fetal DNA (of placental origin) in maternal blood to identify genetic variations leading to disorders.

Prevalence

  1. *Source – Combined prevalence using higher end of published ranges from Gross et al. Prenatal Diagnosis 2011; 39, 259-266;

What are the common conditions that Claria NIPT, NIPT Twins and Claria NIPT Advanced can detect?

Claria NIPT can detect common Aneuploidies and Sex Chromosome Abnormalities.

Aneuploidy (Singleton)

  • Trisomy 21 (Down Syndrome)
  • Trisomy 18 (Edwards’ Syndrome)
  • Trisomy 13 (Patau syndrome)
  • Turner Syndrome (Monosomy X/XO)
  • Klinefelter Syndrome (XXY)
  • Triple X (XXX)
  • Jacob’s Syndrome (XYY)

Advanced

  • Rare Autosomal Aneuploidies (RAA) include trisomies in chromosomes other than 21, 18 and 13 and monosomies in all 22 chromosomes.
  • Claria NIPT Advanced screens for RAAs in addition to Trisomy 13, 18, 21 and sex chromosomes.

Twins

  • Trisomy 21
  • Trisomy 18
  • Trisomy 13

Claria NIPT does not test for the gender of the fetus. MedGenome is a PC & PNDT certified company

Key Highlights of Claria NIPT

1. Comprehensive view of the fetal genome

  • Screens entire fetal genome and not just trisomies in chromosomes 21, 18, and 13

2. Enhanced Test Performance

  • Sensitivity and specificity of >99.9% for Trisomy 21, 18, 13
  • >99% call rate

3. Low Test Failure Rates

  • Claria NIPT offers >99% call rate.

4. Fastest Test results

  • The Claria NIPT offers a fast three-step automated workflow for NIPT
  • The turn around time is less than or equal to 7 working days

5. Extensive Validation on Indian Samples

Claria NIPT is validated using 303 clinical samples from the Indian population, which included both known high risk samples and samples tested with cross platform. The validation successfully identified 51 high-risk cases and the low-risk cases.

Why do you need the NIPT test?

  • Helps identify fetuses at risk of serious chromosomal abnormality
  • Gives reassurance to expecting parents
  • Leads to better management of a child’s genetic health by providing early information.
  • Prepares for the birth and early intervention wherever possible

When can the NIPT test be done?

The NIPT screening test can be performed from as early as 10 weeks of pregnancy.

Who needs to get tested?

All pregnant women who need insight into their baby’s development can avail the test, regardless of their age. Claria NIPT is recommended for all types of pregnancies. Medical societies today support the use of NIPT as the first line of screening for all pregnancies, irrespective of the risk.
For physicians, it is important to recommend this test for pregnancies where:

  • The woman is above 30 years of age.
  • A high risk for abnormality is found serum screening.
  • Certain abnormalities on ultrasound are identified.
  • There is a family history of chromosomal conditions or birth defects.
  • Couples have had a child with a chromosomal disorder.
  • A couple has a history of infertility or pregnancy loss (miscarriages or stillbirths).

How is Claria NIPT better than others?

  • High sensitivity/ specificity for low false positive and negative rates
  • It has an accuracy of over 99.9%
  • Only NIPT to be validated in the Indian patient group
  • Reports fetal fraction in each case, providing greater confidence in the results of the test
  • FREE pre and post-test genetic counselling for all patients
  • Only NIPT to process all samples at our CAP* accredited lab in India, enabling accurate and faster reporting
*: College of American Pathologist (CAP)- This is the highest standard of quality accreditation that is given to a diagnostic lab globally.

Claria NIPT workflow

  • To book the test, talk to our local representative or dial 1800 103 3691 or Book a Test online or diagnostics@medgenome.com
  • A quick and simple blood draw from the mother’s arm, posing no risk to the baby.
  • The sample is shipped to MedGenome and analyzed using Next Generation Sequencing technology.
  • The result is generated within 7 working days of receiving the sample.
  • Free Genetic Counseling is offered to help you understand the results.

Brochures

NIPT

Blog

Gene Therapy: a promising potential treatment modality for LCA

Patient Stories

From early knowledge to early intervention: 22q11.2 deletion, an unheard chromosomal disorder

Free Genetic Counseling by MedGenome Genetic Experts

Please share your details with our genetic experts to answer your queries

Test Menu

Genetic Counselling

Microsites

Collaterals

Contact Us